NIKE (NYSE:NKE) PT Lowered to $115.00 at Guggenheim
NIKE (NYSE:NKE – Free Report) had its price objective decreased by Guggenheim from $130.00 to $115.00 in a report issued on Friday morning, Benzinga reports. Guggenheim currently has a buy rating on the footwear maker’s stock. A number of other research firms have also recently commented on NKE. Evercore ISI lowered their target price on […]
More Stories
Analyzing CAVA Group (CAVA) and The Competition
CAVA Group (NYSE:CAVA – Get Free Report) is one of 76 publicly-traded companies in the “Eating places” industry, but how...
SAB Biotherapeutics (NASDAQ:SABS) & Quantum Genomics Société Anonyme (OTCMKTS:QNNTF) Head to Head Contrast
Quantum Genomics Société Anonyme (OTCMKTS:QNNTF – Get Free Report) and SAB Biotherapeutics (NASDAQ:SABS – Get Free Report) are both medical...
MariaDB (NYSE:MRDB) vs. Cellebrite DI (NASDAQ:CLBT) Head to Head Analysis
MariaDB (NYSE:MRDB – Get Free Report) and Cellebrite DI (NASDAQ:CLBT – Get Free Report) are both computer and technology companies,...
Brokerages Set Corpay, Inc. (NYSE:CPAY) Price Target at $335.20
Shares of Corpay, Inc. (NYSE:CPAY – Get Free Report) have been given a consensus recommendation of “Moderate Buy” by the...
Hudbay Minerals Inc. (NYSE:HBM) Given Consensus Recommendation of “Buy” by Brokerages
Shares of Hudbay Minerals Inc. (NYSE:HBM – Get Free Report) (TSE:HBM) have been given an average rating of “Buy” by...
Analysts Set Converge Technology Solutions Corp. (TSE:CTS) Target Price at C$6.63
Shares of Converge Technology Solutions Corp. (TSE:CTS – Get Free Report) have been assigned an average recommendation of “Moderate Buy”...